The Division for Molecular Pharmacology (MP) serves members applying approaches of biochemistry, biophysics, genetics, and molecular biology to study molecular mechanisms of drug action, regardless of the class of drug. Areas of interest include (but are not limited to): drug receptor-effector coupling and its regulation (e.g. receptor structure/function, G proteins, kinases, phosphatases, and second messenger synthesis and degradation), voltage- and ligand-gated ion channels, antimicrobial and antineoplastic drug action, steroid and growth factor receptors, gene regulation, and identification of molecular targets for drugs.
- To develop programming and sponsor symposia and colloquia at the ASPET Annual Meeting at Experimental Biology
- To sponsor other meetings of interest for our division members
- To promote the career development of junior members
- To foster interactions between academia and industry
- To establish a presence for the division on social media
Posting on social media about the MP division? Use #ASPETMP.
August 08, 2019
On June 7, 2019 it was announced by Buckingham Palace that Her Majesty Queen Elizabeth II had appointed Professor V. Craig Jordan, OBE as Companion of the Most Distinguished Order of St. Michael and St. George (CMG) for services to women’s health.
August 07, 2019
The Bow Foundation is announcing two new funding opportunities for independent investigators and postdocs working on GNAO1-related research.
July 10, 2019
ASPET members Michelle Kimple, David A. Gewirtz, Rachel Fenske, and Austin Reuter are recognized for their recent accomplishments.
Last Updated: June 6, 2019